UPDATE 2-ResTORbio stops testing lead drug for respiratory illness; shares crash
November 15, 2019 at 10:01 AM EST
Shares of drug developer ResTORbio Inc plunged more than 80% to a record low on Friday after a late-stage trial failure prompted the company to abandon testing its lead drug as a treatment for respiratory illness.
